Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.88
-0.12 (-1.09%)
At close: Jun 18, 2026, 4:00 PM EDT
11.05
+0.17 (1.60%)
After-hours: Jun 18, 2026, 7:59 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $864.2 million as of June 18, 2026. Its market cap has increased by 163.37% in one year.
Market Cap
864.20M
Enterprise Value
1.23B
1-Year Change
163.37%
Ranking
Category
Stock Price
$10.88
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $864.20M, an increase of 63.95%. That is a compound annual growth rate of 7.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 864.20M | -26.77% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 866.18M |
| Theravance Biopharma | 860.42M |
| ORIC Pharmaceuticals | 860.23M |
| Sana Biotechnology | 848.72M |
| Alpha Tau Medical | 843.15M |
| Odyssey Therapeutics | 843.00M |
| Janux Therapeutics | 835.49M |
| Kura Oncology | 834.48M |